Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23913)

• Formulation Name: Tafenoquine 150 mg tablet
• Company: Glaxosmithkline

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Tafenoquine	(DM1XT4N)	Malaria	1F40-1F45	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Haematite red	(E00236)	14833	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 4000	(E00654)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent